Drug repurposing approach against chikungunya virus: an in vitro and in silico study (vol 13, 1132538, 2023)

被引：0
|
作者：
Kasabe, Bhagyashri [1 ]
Ahire, Gunwant [2 ]
Patil, Poonam [2 ]
Punekar, Madhura [2 ]
Davuluri, Kusuma Sai [2 ]
Kakade, Mahadeo [2 ]
Alagarasu, Kalichamy [2 ]
Parashar, Deepti [2 ]
Cherian, Sarah [1 ]
机构：
[1] Indian Council Med Res ICMR, Natl Inst Virol, Bioinformat Grp, Pune, Maharashtra, India
[2] Indian Council Med Res ICMR, Natl Inst Virol, Dengue & Chikungunya Grp, Pune, Maharashtra, India
来源：
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2023年 / 13卷
关键词：
chikungunya virus (CHIKV); drug repurposing; structural and non-structural proteins; in silico screening; in vitro validation;
D O I：
10.3389/fcimb.2023.1226054
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
下载
收藏
页数：5
相关论文
共 50 条
  • [31] In silico screening and identification of potential drug against p300 acetyltransferase activity in breast cancer via drug repurposing approach
    Sarkar, Shilpi
    Kandasamy, Thirukumaran
    Shome, Rajib
    Ghosh, Siddhartha Sankar
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023,
  • [32] In vitro and in Silico Study to Evaluate the Effectiveness of Quercitrin as Antiviral Drug to Dengue Virus
    Dewi, Beti Ernawati
    Ratningpoeti, Edianti
    Desti, Hidayati
    Angelina, Marissa
    4TH BIOMEDICAL ENGINEERING'S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, HEALTH, AND MEDICAL DEVICES: PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM OF BIOMEDICAL ENGINEERING (ISBE) 2019, 2019, 2193
  • [33] Drug repurposing approach for the identification and designing of potential E6 inhibitors against cervical cancer: an in silico investigation
    Kumar, Avinash
    Rathi, Ekta
    Kini, Suvarna G.
    STRUCTURAL CHEMISTRY, 2020, 31 (01) : 141 - 153
  • [34] Drug repurposing approach for the identification and designing of potential E6 inhibitors against cervical cancer: an in silico investigation
    Avinash Kumar
    Ekta Rathi
    Suvarna G. Kini
    Structural Chemistry, 2020, 31 : 141 - 153
  • [35] Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches
    Nath, Mitul
    Bhowmik, Deep
    Saha, Satabdi
    Nandi, Rajat
    Kumar, Diwakar
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [36] Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches
    Mitul Nath
    Deep Bhowmik
    Satabdi Saha
    Rajat Nandi
    Diwakar Kumar
    Scientific Reports, 14
  • [37] Insecticide discovery by drug repurposing: new synergistic inhibitors against Periplaneta americana (vol 47, pg 17234, 2023)
    Chafer-Dolz, Beatriz
    Cecilia, Jose M.
    Imbernon, Baldomero
    Nunez-Delicado, Estrella
    Casana-Giner, Victor
    Ceron-Carrasco, Jose P.
    NEW JOURNAL OF CHEMISTRY, 2023, 47 (37) : 17607 - 17607
  • [38] In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19 (vol 103, 105318, 2022)
    Mirmohammadi, Seyedeh Mozhdeh
    Kianmehr, Anvarsadat
    Sabbaghian, Amir
    Mohebbi, Alireza
    Shahbazmohammadi, Hamid
    Sheikharabi, Mehdi
    Bazzi, Zahra
    INFECTION GENETICS AND EVOLUTION, 2022, 104
  • [39] Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: : A dual in silico and in vitro approach
    Kumari, Diksha
    Jamwal, Vishwani
    Singh, Ajeet
    Singh, Shashank K.
    Mujwar, Somdutt
    Ansari, Md. Yousuf
    Singh, Kuljit
    ACTA TROPICA, 2024, 258
  • [40] In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach
    Chandel, Vaishali
    Raj, Sibi
    Rathi, Brijesh
    Kumar, Dhruv
    CHEMICAL BIOLOGY LETTERS, 2020, 7 (03): : 166 - 175
12345